Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?

Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy? Publisher Pubmed

Hormati A^{1, 2} ; Ghadir MR¹ ; Zamani F² ; Khodadadi J³ ; Khodadust F⁴ ; Afifian M⁵ ; Aminnejad R^{6, 7} ; Ahmadpour S¹

Show Affiliations

1. Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran
2. Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
3. Department of Infectious Diseases, School of Medicine, Kamkar-Arabnia Hospital, Qom University of Medical Sciences, Qom, Iran
4. Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
5. Health Information Technology, Tehran University of Medical Sciences, Tehran, Iran
6. Department of Anisthesiology and Ciritical Care, Qom University of Medical Sciences, Qom, Iran
7. Department of Anisthesiology and Ciritical Care, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Immunology Letters Published:2020

Abstract

[No abstract available]

2. Jak Inhibition As a New Treatment Strategy for Patients With Covid-19, International Archives of Allergy and Immunology (2020)

3. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)

4. Covid-19 in Iran: Forecasting Pandemic Using Deep Learning, Computational and Mathematical Methods in Medicine (2021)

5. Investigating How Interleukin 6 Serum Level, Blood Group Type, and Underlying Diseases Are Associated in Patients Admitted to the Covid-19 Intensive Care Unit: A Retrospective Study, Open Public Health Journal (2023)

6. Interleukin-6 Role in the Severity of Covid-19 and Intensive Care Unit Stay Length, Cellular and Molecular Biology (2020)

7. Role of Serology Tests in Covid-19 Nonhospitalized Patients: A Cross-Sectional Study, PLoS ONE (2022)

8. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Esmaeil Mohammadnejad (1)

Style	Citing Format
MLA	Hormati A, et al.. "Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?." Immunology Letters, vol. 224, no. , 2020, pp. 12-13.
APA	Hormati A, Ghadir MR, Zamani F, Khodadadi J, Khodadust F, Afifian M, Aminnejad R, Ahmadpour S (2020). Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?. Immunology Letters, 224(), 12-13.
Chicago	Hormati A, Ghadir MR, Zamani F, Khodadadi J, Khodadust F, Afifian M, Aminnejad R, Ahmadpour S. "Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?." Immunology Letters 224, no. (2020): 12-13.
Harvard	Hormati A et al. (2020) 'Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?', Immunology Letters, 224(), pp. 12-13.
Vancouver	Hormati A, Ghadir MR, Zamani F, Khodadadi J, Khodadust F, Afifian M, et al.. Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?. Immunology Letters. 2020;224():12-13.
BibTex	@article{ author = {Hormati A and Ghadir MR and Zamani F and Khodadadi J and Khodadust F and Afifian M and Aminnejad R and Ahmadpour S}, title = {Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy?}, journal = {Immunology Letters}, volume = {224}, number = {}, pages = {12-13}, year = {2020} }
RIS	TY - JOUR AU - Hormati A AU - Ghadir MR AU - Zamani F AU - Khodadadi J AU - Khodadust F AU - Afifian M AU - Aminnejad R AU - Ahmadpour S TI - Are There Any Association Between Covid-19 Severity and Immunosuppressive Therapy? JO - Immunology Letters VL - 224 IS - SP - 12 EP - 13 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract